CANTEX PHARMACEUTICALS OBTAINS EXCLUSIVE WORLDWIDE RIGHTS TO INTELLECTUAL PROPERTY FROM GEORGETOWN UNIVERSITY FOR AZELIRAGON AS A POTENTIAL TREATMENT OF CANCER-RELATED COGNITIVE DECLINE
New Real-World Evidence from Personalized Trials Calls for Rethinking the Standard of Care for Non-Responders to Autoimmune Therapies
CSOFT to Host June Soiree at Harvard Art Museums, Exhibit at 2023 DIA Global in Boston
Solutionreach Announces Cutting-Edge Generative AI Capabilities for Review Management
Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform
America’s Best Wings: Everything You Need to Know
Mazamet: Culture invites itself to the Pays d’Autan hospital
Canada will require a warning to be printed on every cigarette
Can Crimean-Congo hemorrhagic fever happen in France?
Sexual health: 400 awareness-raising actions in Occitania at the beginning of June
Hautes-Pyrenees. “Let everyone form an opinion on this unique site”: a participatory meeting around the future of hospitals
Cantex to Expand Collaboration with Georgetown’s Lombardi Comprehensive Cancer Center WESTON, Fla., June 1, 2023 /PRNewswire/ — Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on...